BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31196853)

  • 21. Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy.
    Hingorani M; White CL; Zaidi S; Merron A; Peerlinck I; Gore ME; Nutting CM; Pandha HS; Melcher AA; Vile RG; Vassaux G; Harrington KJ
    Clin Cancer Res; 2008 Aug; 14(15):4915-24. PubMed ID: 18676766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.
    Hingorani M; White CL; Zaidi S; Pandha HS; Melcher AA; Bhide SA; Nutting CM; Syrigos KN; Vile RG; Vassaux G; Harrington KJ
    Mol Ther; 2010 Sep; 18(9):1599-605. PubMed ID: 20588260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
    Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
    PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
    Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
    Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
    Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Bone Marrow Mesenchymal Stem Cells Modified Hybrid Baculovirus-Adeno-Associated Viral Vectors Targeting
    Wang J; Kong D; Zhu L; Wang S; Sun X
    Hum Gene Ther; 2020 Dec; 31(23-24):1300-1311. PubMed ID: 32940055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of Bone Marrow Mesenchymal Stem Cell-Mediated Synthetic Radiosensitive Promoter-Combined Sodium Iodide Symporter for Radiogenetic Ovarian Cancer Therapy.
    Shi S; Li F; Wu L; Zhang L; Liu L
    Hum Gene Ther; 2021 Aug; 32(15-16):828-838. PubMed ID: 33339472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
    Kitzberger C; Shehzad K; Morath V; Spellerberg R; Ranke J; Steiger K; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
    Mol Ther Oncolytics; 2023 Sep; 30():238-253. PubMed ID: 37701849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
    Kim YH; Lee DS; Kang JH; Lee YJ; Chung JK; Roh JK; Kim SU; Lee MC
    J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
    Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
    Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
    [No Abstract]   [Full Text] [Related]  

  • 33. Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
    Mansfield DC; Kyula JN; Rosenfelder N; Chao-Chu J; Kramer-Marek G; Khan AA; Roulstone V; McLaughlin M; Melcher AA; Vile RG; Pandha HS; Khoo V; Harrington KJ
    Gene Ther; 2016 Apr; 23(4):357-68. PubMed ID: 26814609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.
    Grünwald GK; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Göke B; Holm PS; Spitzweg C
    Gene Ther; 2013 Jun; 20(6):625-33. PubMed ID: 23038026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
    Kim SH; Chung HK; Kang JH; Kim KI; Jeon YH; Jin YN; Yun CO; Chung JK
    Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
    Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
    Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.